
Adam Sowalsky
@sowalsky
Translational scientist at NCI/NIH @nciccr_gmb. Giving prostate cancer the finger. All tweets are my own.
ID: 69672756
https://scholar.google.com/citations?user=_1JXRTcAAAAJ&hl=en 28-08-2009 19:31:36
684 Tweet
1,1K Followers
334 Following


Paper Drop from the #ShafiLab ⬇️ Center for Prostate Disease Research @AmerCancerCEO NCI CCR GU Malignancies PCF Science Gregory Chesnut Adam Sharp EllisLab_ Allen Su Uniformed Services University biorxiv.org/content/10.110…

In the inaugural NIH Liquid Biopsy conference was a two-day meeting consisting of lectures, posters, breakout sessions and roundtable discussions. Thank you to our speakers for making it successful! NIH Intramural @NCIResearchCtr @nih_nhlbi NIH National Cancer Institute @NICHD_NIH @TheBethesdaLabs




Can we democratize #PrecisionOncology through accurate response prediction based solely on tumor H&E images🔬?? Our ENLIGHT-DeepPT framework can help make it happen! We are ecstatic to share our latest work in #DigitalPathology, just out in Nature Cancer! rdcu.be/dMB0u

📣🎉Congratulations Dr. Fatima Karzai Fatima Karzai, M.D. NCI CCR GU Malignancies @NCIResearchCtr National Cancer Institute 🎉👏🏼 🔬For more on her #ProstateCancer research program 🧬 ccr.cancer.gov/staff-director…



Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer out on Cancer Discovery This study investigates how androgen-dependent #ProstateCancer evades immune detection by downregulating major histocompatibility complex class I


Latest journey in #prostatecancer cell plasticity. Team effort Christopher Sweeney, MBBS Katherine Morel Beatriz Work stems from previous Christopher Sweeney, MBBS investigations in NFkB regulation by tristetraprolin (TTP; gene ZFP36), and generation of the NFkBi dimethylaminoparthenolide (DMAPT)
